Myriad Genetics INC
SEC CIK 899923 · MYGN · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Skovronsky Daniel | Director | filed 2020 - 2026 |
| Raha Samraat S. | Director · President and CEO | filed 2023 - 2026 |
| Kumar Rashmi | Director | filed 2020 - 2026 |
| Bisaro Paul | Director | filed 2022 - 2026 |
| Dreismann Heinrich | Director | filed 2022 - 2026 |
| Phanstiel S. Louise | Director | filed 2009 - 2026 |
| Reitan Colleen F | Director | filed 2019 - 2026 |
| Newcomer Lee Nisley | Director | filed 2019 - 2026 |
| Davis Mark Steven | Director | filed 2024 - 2026 |
| Diaz Paul J | Director · President and CEO | filed 2020 - 2025 |
| Spiegelman Daniel K | Director | filed 2020 - 2024 |
| Langer Dennis | Director | filed 2006 - 2022 |
| Dreismann Heinrich | Director | filed 2010 - 2021 |
| Gilbert Walter PHD | Director | filed 2006 - 2019 |
| Best Lawrence C | Director | filed 2009 - 2019 |
| Henderson John T | Director | filed 2006 - 2019 |
| Meldrum Peter D | Director · President & C.E.O. | filed 2006 - 2015 |
| Wilson Linda S | Director | filed 2006 - 2010 |
| Skolnick Mark H | Director · Chief Scientific Officer | filed 2006 - 2009 |
| Belle Gerald P. | Director | filed 2007 - 2009 |
| Attiyeh Robert S | Director | filed 2006 - 2008 |
| Hayes Arthur Hull JR | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Donnelly Brian J | Chief Commerical Officer | filed 2025 - 2026 |
| Jampa Raj | Chief Technology Officer | filed 2026 - 2026 |
| Verratti Mark | President, Myriad Neuroscience | filed 2017 - 2026 |
| Muzzey Dale | Chief Scientific Officer | filed 2022 - 2026 |
| Wheeler Benjamin Richard | Chief Financial Officer | filed 2025 - 2026 |
| Solaiman Shereen | Chief People Officer | filed 2023 - 2026 |
| Haas Kevin Richard | SVP Technology | filed 2021 - 2026 |
| Fox Jennifer Lynne | Chief Legal Officer | filed 2024 - 2026 |
| Ancona Margaret | See Remarks | filed 2021 - 2025 |
| Munk Natalie | Chief Accounting Officer | filed 2022 - 2025 |
| Leffler Scott J. | Chief Financial Officer | filed 2024 - 2025 |
| Wong Pamela | Chief Legal Officer | filed 2021 - 2024 |
| Riggsbee Richard Bryan | Chief Financial Officer | filed 2014 - 2024 |
| Lambert Nicole | See Remarks | filed 2019 - 2023 |
| Hart Jayne B. | See Remarks | filed 2011 - 2023 |
| Santa Eric | Former Chief Growth Officer | filed 2021 - 2022 |
| Lanchbury Jerry S | Senior V.P. - Research | filed 2006 - 2022 |
| Parkinson Paul | Fmr EVP Strategy & Innovation | filed 2020 - 2021 |
| Jackson Benjamin | Former E.V.P., General Counsel | filed 2019 - 2021 |
| Ford Alexander | President, MWH | filed 2015 - 2020 |
| Capone Mark Christopher | President, MGL | filed 2006 - 2019 |
| King Gary A. | Exec. VP International Ops | filed 2010 - 2019 |
| Mcdade Ralph L | President Myriad RBM, Inc. | filed 2014 - 2019 |
| Tobin Bernard | President Crescendo BioScience | filed 2015 - 2019 |
| Marsh Richard M | V.P., General Counsel | filed 2006 - 2018 |
| Sanders Walter Lloyd | President Myriad Oncology | filed 2018 - 2018 |
| Wenstrup Richard | Chief Medical Officer | filed 2015 - 2016 |
| Drosos Virginia | President Assurex Health | filed 2016 - 2016 |
| Evans James S | Vice President Finance | filed 2006 - 2014 |
| Harrison Robert Gardner | Chief Information Officer | filed 2008 - 2014 |
| Rogers Ronald S. | Exec VP Corp Communications | filed 2013 - 2014 |
| Hagstrom William A | Pres. Crescendo Bioscience | filed 2014 - 2014 |
| Benson T Craig | President, Myriad RBM | filed 2011 - 2013 |
| Critchfield Gregory C | President Myriad Genetic Labs | filed 2006 - 2009 |
| Hobden Adrian N | Pres. Myriad Pharmaceuticals | filed 2006 - 2009 |
| Laslie W Wayne | Chief Operating Officer, MPI | filed 2006 - 2009 |
| Hockett William A III | V. P. of Corp Communications | filed 2006 - 2008 |
| Moyes JAY M | Chief Financial Officer | filed 2006 - 2007 |
| Simon S George | V.P. Business Development | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.